Mathilde Krim, amfAR, and the prevention of HIV infection among injecting drug users: A brief history

AIDS Patient Care and STDs

Volumn 20, Issue 7, 2006, Pages 467-471

  Des Jarlais, Don C ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; EPIDEMIC; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; REVIEW; UNITED STATES; VIRUS TRANSMISSION;

COMMUNICABLE DISEASE CONTROL; FOUNDATIONS; HISTORY, 20TH CENTURY; HIV INFECTIONS; HUMANS; NEEDLE-EXCHANGE PROGRAMS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 33746097401     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.467     Document Type: Review

References (27)

1. Hagan H, Des Jarlais D, Purchase D. The Tacoma syringe exchange studies: Public health practice influences research. In: Sorensen J, Rawson R, Guydish J, Zweben J (eds.) Drug Abuse Treatment Through Collaboration: Practice and Research Partnerships that Work. Washington, DC: American Psychological Association; 2003.
2. Hagan H, Thiede H. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health 2000;77:369-382.
3. Des Jarlais DC, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: uUse of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health 2005;95(8):1439-1444.
4. Strathdee S, Galai N, Safaeian M, et al. Sex differences in risk factors for HIV seroconversion among injection drug users: A 10-year perspective. Arch Intern Med 2001;161(10):1281-1288.
5. Santibanez S, Garfein R, Swartzendruber A, Purcell DW, Paxton L, Greenberg A. Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. J Urban Health 2006;83(1):86-100.
6. Kral AH, Lorvick J, Gee L, et al. Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998. Am J Epidemiol 2003;157(10):915-922.
7. Centers for Disease Control and Prevention. Acquired Immunodeficiency Syndrome (AIDS) Weekly Surveillance Report-United States. Atlanta: Centers for Disease Control and Prevention, 1984.
8. Anderson W. The New York needle trial: The politics of public health in the age of AIDS. Am J Public Health 1991;81:1506-1517.
9. Oliver K, Maynard H, Friedman SR, Des Jarlais DC (eds.) Behavioral and Community Impact of the Portland Syringe Exchange Program. Washington, DC: National Academy of Sciences; 1994. Proceedings of the Workshop in Needle Exchange and Bleach Distribution Programs.
10. Oliver K, Friedman S, Maynard H, Magnuson L, Des Jarlais D. Impact of a needle exchange program on potentially infectious syringes in public places. J Acquir Immune Defic Syndr 1992;5(5):534.
11. Hagan H, Des Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injecting drug users participating in the Tacoma syringe exchange program. Am J Public Health 1995;85(11):1531-1537.
12. Des Jarlais D, Hagan H, Friedman S, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995;274(15):1226- 1231.
13. National Commission on AIDS. Full report: The twin epidemics of substance use and HIV. Washington, DC: Dogwood Center; July 1991.
14. Kaplan EH. Needle exchange or needless exchange? The state of the debate. Infect Agents Dis 1992;1: 92-98.
15. Kaplan EH, O'Keefe E. Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces 1993;23:7-26.
16. Kaplan E, Heimer R. What happened to HIV transmission among HTV drug injectors in New Haven? Chance: New Direct Stat Comput 1993;6:9-14.
17. Kaplan EH, Khoshnood K, Heimer R. A decline in HIV infected needles returned to New Haven's needle exchange program: Client shift or needle exchange? Am J Public Health 1994;84(12):1991-1994.
18. Normand J, Vlahov D, Moses LE, eds. Preventing HIV transmission: The role of sterile needles and bleach. Washington, D.C.: National Academy Press/National Research Council/Institute of Medicine, 1995.
19. NASEN. North American syringe exchange network (NASEN). Newsworks 1994;3:1.
20. Des Jarlais DC, Friedman SR, Novick D, et al. HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA 1989;261:1008-1012.
21. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996;348:987-991.
22. McKnight C, Des Jarlais D, Perlis T, et al. Update: Syringe exchange programs-United States, 2002. Morb Mortal Wkly Rep 2005;54(27):673-676.
23. Paone D, Des Jarlais DC, Clark J, et al. Syringe Exchange Programs-United States, 1994-1995. Morb Mortal Wkly Rep 1995;44(37):684-684,691.
24. Paone D, Des Jarlais D, Clark J, et al. Update: Syringe-exchange programs-United States, 1996. Morb Mortal Wkly Rep 1997;46(24):565-567.
25. Paone D, Des Jarlais DC, Singh MP, et al. Update: Syringe exchange programs-United States, 1997. Morb Mortal Wkly Rep 1998;47(31):652-655.
26. Singh MP, McKnight CA, Paone D, et al. Update: Syringe exchange programs-United States, 1998. Morb Mortal Wkly Rep 2001;50:384-387.
27. Quan VM, Steketee RW, Valleroy L, Weinstock H, Karon J, Janssen R. HIV incidence in the United States, 1978-1999. J Acquir Immune Defic Syndr 2002;31: 188-201.